Efficacy and safety of a <scp>VWF</scp>/<scp>FVIII</scp> concentrate (wilate^®) in inherited von Willebrand disease patients undergoing surgical procedures

Abstract

Wilate^® demonstrated effective prevention and treatment of bleeding in inherited VWD patients undergoing surgery, with no clinically significant safety concerns.